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Abstract
Background: Family history is a known risk factor for type 2 diabetes (T2DM), and more so in the presence of
overweight. This study aims to develop and evaluate the effectiveness of a new lifestyle education programme
‘DiAlert’ targeted at 1st degree relatives of people with T2DM and overweight. In view of the high risk for diabetes
and cardiovascular disease in immigrants from Turkish origin living in Western Europe, a culturally appropriate
Turkish version of DiAlert will be developed and tested.
Methods/design: In this RCT, 268 (134 Dutch and 134 Turkish) overweight 1st degree relatives of patients with
T2DM will be allocated to either the intervention or control group (leaflet). The intervention DiAlert aims to
promote intrinsic motivation to change lifestyle, and sustain achieved behaviour changes during follow-up. Primary
outcome is weight loss. Secondary outcomes include biological, behavioural and psychological indices, along with
process indicators. Measurements will take place at baseline and after 3 and 9 months. Changes in outcomes are
tested between intervention and control group at 3 months; effects over time are tested within and between both
ethnic groups at 3 and 9 months.
Discussion: The DiAlert intervention is expected to be more effective than the control condition in achieving
significant weight loss at 3 months, in both Dutch and Turkish Dutch participants.
Trial registration: Netherlands National Trial Register (NTR): NTR2036
Background
The prevalence of people with type 2 diabetes (T2DM) in
the general population is reaching epidemic proportions
in many countries, with the total number of people with
T2DM projected to rise to 366 million in 2030 worldwide
[1]. It is therefore imperative that strategies to prevent
the disease are implemented, this might include targeting
high-risk populations to increase effectiveness. The
increased prevalence is associated with lifestyle depen-
dent risk factors, including being overweight, physical
inactivity and unhealthy diet. In addition, the chance of
developing T2DM is two to fourfold greater for people
with a positive family history (FH) compared to those
without, depending on the number of and the distance to
the affected family members [2-4]. Since members of
families share the same variations of genes, environment
and behaviour patterns, family history information could
possibly be used for screening and as a vehicle to moti-
vate people at risk for T2DM to change behaviour [5,6].
However, targeting people with a positive family history
of T2DM to promote lifestyle changes is an under-
explored prevention strategy. In a review [7] we found
only three randomised studies in the literature that have
reported on the effectiveness of lifestyle-oriented inter-
ventions specifically targeted at individuals with a FH of
diabetes. Remarkably, none of these trials addressed FH
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risk information and its implications for education strate-
gies to change lifestyle. Risk information based on family
history is of substantial importance in the DiAlert educa-
tion programme.
Evidence from large prevention studies shows that the
risk of developing T2DM can effectively be reduced by
almost 60% in people at risk for diabetes as a result of
lifestyle changes resulting in sustained modest weight
loss [8,9], with persistent benefits over a longer follow-
up of at least 10 years [10]. Among the participants in
the Diabetes Prevention Program in the US 66% of the
male and 71% of the female participants had a first
degree relative with diabetes [11] and results from the
Finnish Diabetes Prevention Study (DPS) have con-
firmed the effectiveness of weight loss by lifestyle
changes to reduce the risk of diabetes independent of
genetic or familial risk of T2DM [12].
To date, the majority of the diabetes prevention studies
have evaluated intensive lifestyle and behaviour change
interventions, most often including frequent sessions and
one-to-one counselling. Translating the evidence to public
health is a challenge, and there is a clear need for targeted
interventions that balance feasibility and effectiveness to
fit primary care and community settings [13]. Evidence
from a pragmatic education programme (PREPARE) in
the UK showed that 3 hours structured group-based edu-
cation incorporating a pedometer is an effective strategy
for improving glucose tolerance in people at risk, even
after 24 months [14,15]. This confirms the effectiveness of
short theory based educational interventions aimed at peo-
ple who are at risk for T2DM, yet not medically ill and
unlikely to experience serious symptom distress or func-
tional impairments to prevent T2DM.
Increasing evidence suggests that family history informa-
tion could contribute to tailored health information, which
is potentially more effective in promoting lifestyle changes
than health information aimed at ‘anyone at risk’ [6]. We
therefore developed DiAlert, a theory-based lifestyle edu-
cation program aimed at overweight first-degree relatives
of patients with T2DM, to help them reduce their risk of
diabetes and related cardiovascular disease. The group-
based intervention consists of two sessions of 150 minutes
of education with focus on achieving moderate weight
loss, by means of improved diet and physical activity.
Here we report on the study design of the DiAlert study
and the development and evaluation protocol of the ran-
domised controlled trial (RCT). In this RCT the effective-
ness of DiAlert will not only be evaluated in an ethnic
Dutch population but in a population from Turkish origin
living in the Netherlands as well. Turkish people are an
important group of immigrants in our country, according
to figures from 2010 383,957 people (2.3%) of the Dutch
population is of Turkish origin [16] and they have a higher
prevalence of T2DM (5.6%) as compared to the Dutch
population (3.1%) [17]. The increased risk of T2DM in
this group is believed to be due to familial susceptibility
interacting with an unhealthy lifestyle, characterized by
high energy and saturated fat intake, along with low levels
of physical activity, being overweight and low socio-
economic status [18-20]. Few studies have looked at tar-
geted lifestyle interventions in this group and most relate
to secondary prevention [21,22]. Comparisons between
the two ethnic groups could contribute to the external
validity of DiAlert in the future.
Aims of the trial
The primary aim of this randomised controlled trial is
to test the hypothesis that DiAlert can be effectively uti-
lised to promote weight loss in individuals with a first
degree relative with T2DM and being overweight at
three months, and thereby help reduce their risk of
developing diabetes. In addition, we expect to observe
significant changes in metabolic, psychological and
behavioural parameters 3 and 9 months following the
intervention.
Methods/Design
Study design
The DiAlert-study is a randomised controlled trial (RCT)
testing the effectiveness of a lifestyle education pro-
gramme in two groups: ethnic Dutch participants and
participants of Turkish origin living in the Netherlands.
We aim to include 134 Dutch and 134 Turkish over-
weight first degree relatives of T2DM patients. Measure-
ments are scheduled at baseline, 3 and 9 months after the
last group session (see Figure 1).
Information is lacking on the standard deviation of the
percentage of weight change over 3 and 9 months of fol-
low-up in a population at risk for T2DM due to family
history and overweight. This study is powered to detect
a difference of at least 3.5% body weight at 3 months
after randomisation (derived from DPP [8]). Assuming a
conservative standard deviation of 6%, a power of 80%,
and a significance of 0.05 we require a sample size of 50
participants per group at that time point. If during
initial screening T2DM is assessed participants will be
excluded from the study (10%). Furthermore, we assume
an attrition rate of approximately 15%. Therefore we
aim to over sample (25%), and include 67 persons in
each group (Dutch group: 67/67 Turkish group: 67/67)
Study population
Eligible are first-degree relatives of T2DM patients
(father, mother, brothers or sisters, sons or daughters),
between 25 and 65 years of age, and overweight (Body
Mass Index of ≥ 25 or waist circumference > 88 cm for
females and > 102 cm for males) from ethnic Dutch or
Turkish origin.
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Exclusion criteria are: people diagnosed with type 1 or
2 diabetes, currently under medical treatment for
ischemic heart disease or cancer, diagnosed with a psy-
chiatric disorder, pregnancy or physically/mentally too
impaired to participate in the study (e.g. unable to come
to the location of the assessments and interventions)
and not being able to write and read in Dutch or
Turkish.
 
*The same study procedure is performed in both ethnic groups separately. 
Turkish / Dutch group* 
Invitation people FH by: 
 
 GP or outpatient clinic 
 Advertisements, leaflets and brochures 
 
Intervention group 
N= 67 (Dutch) / N= 67 (Turkish)  
Excluded 
 Not meeting inclusion criteria  
 Refused to participate  
 Non response 
Randomisation 
Exclusion: 
screening of 
T2DM (10%) 
Informed consent 
Loss to follow-up 
Positive reply  
 
N= 134 (Dutch) / N=134 (Turkish)  
Control group 
N= 67 (Dutch) / N= 67 (Turkish)  
Follow-up measurement T1 
 (week 13) 
Follow-up measurement T2 
 (week 37) 
Baseline measurement T0 
(week 1) 
Baseline measurement T0 
(week1) 
Group sessions 2x 150 minutes 
(week 1-2) 
Follow-up measurement T1 
(week 13) 
Follow-up measurement T2 
 (week 37) 
Newsletter 3 (week 21) 
Newsletter 4 (week 30) 
Newsletter 2 (week 6) 
Newsletter 1 (week 3) 
Written information + brochure 
heredity and diabetes (week 1) 
Loss to follow-up 
Figure 1 Participant flow. A detailed participant flowchart of the DiAlert study.
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Setting
The study population will be recruited in the area of
Amsterdam city, the Netherlands, through two strate-
gies: First, GP practices and outpatient clinics will be
approached. Patients from GP practices registered with
a positive family history and known overweight will be
invited by their GP. The second strategy involves an
open recruitment strategy through advertisements in
local newspapers, leaflets and posters in pharmacies,
waiting rooms of GP practices and outpatient clinics. A
website with information for participants and profes-
sionals to inform people about the study is made avail-
able on the internet (http://www.dialert.nl). People can
enrol in the study by sending an e-mail or completing a
form to be sent by mail. Participation in the DiAlert
study is free of charge for all participants. DiAlert group
sessions will be delivered in local GP practices and in
the outpatient clinic of the VU University Medical Cen-
ter in Amsterdam facilitated by certified health educa-
tors of PRISMA (Pro-active Interdisciplinary Self-
Management) [23], who received an additional 4 hours
of specific DiAlert training.
Treatment allocation
After receiving a signed informed consent form from the
participants, randomisation will be performed with sealed
envelopes. Members of the same family or household
participating in the study will be clustered. This will be
done to stimulate cohesion in the intervention groups,
and to prevent contamination of the intervention effect
due to reciprocal communication about the intervention
or control condition among family members.
Control group
Participants in the control group receive written infor-
mation about diabetes risk and lifestyle advice to pre-
vent T2DM and a brochure about heredity and diabetes
from the Dutch Diabetes Foundation.
Intervention group
Participants allocated to the intervention group will be
invited to take part in the group-based intervention.
Group size is approximately ten participants and the pro-
gramme consists of two sessions of 150 minutes over two
consecutive weeks and 4 newsletters during the next 6
months. For the timing of newsletter mailings see Figure 1
participants flow.
Intervention
The DiAlert intervention is based on the theory-based
diabetes self-management programme PRISMA that was
adapted from DESMOND (Diabetes Education for Self-
Management in Ongoing and Newly Diagnosed) for the
Netherlands [23,24]. DESMOND and PRISMA (here-
after: PRISMA) consist of two interactive group sessions
and have shown to be successful at initiating behaviour
change in individuals with T2DM [24]. To adapt the
program for participants at risk for T2DM we per-
formed a review of existing lifestyle interventions for
people with a positive family history of T2DM [7] and
consulted different experts.
DiAlert is based on social cognitive behavioural the-
ories, in particular the Health Action Process Approach
(HAPA) [25]. HAPA identifies three key determinants of
initial change: risk perception, self efficacy and outcome
expectancies, leading to intentions and action for health
behaviour change. Table 1 provides an overview of the
DiAlert modules and aims. In brief, the sessions include
explorations of knowledge, impact and concern about
T2DM, discussing risk factors for T2DM, insulin resis-
tance and loss of beta cell function, recommendations for
balancing energy intake and energy expenditure, goals
setting and action planning.
Like PRISMA, DiAlert encourages participants to con-
sider their personal risk factors and choose specific goals
of behaviour changes by using a non-didactic learning
approach. Through eliciting personal stories and respect-
fully exploring and discussing participants ‘personal mod-
els’ [26] and barriers, the stage is set for reviewing the
need for and benefits of behaviour changes, with a focus
on healthy food choices and increasing leisure physical
activities resulting in a personal action plan to change
health behaviour.
A participant manual was developed after investigation
of printed education materials of other lifestyle interven-
tions and health promotion leaflets. The manual provides
background to sessions and contains information about
diabetes prevention, including risk information, tips and
tricks to enhance self-efficacy and outcome expectancies
for diet and physical activity, resources for the partici-
pants such as a table of caloric values and worksheets for
the homework assignment and the participants’ action
plan. In addition, four newsletters will be sent by mail
during the follow-up (see Figure 1) providing information
on health behaviour change, links to relevant websites,
and ‘tips and tricks’ to stay on track with behavioural
changes, physical activity resources in the neighbourhood
and recipes for healthy cooking.
To enhance effectiveness and sustainability, partici-
pants will be informed about and encouraged to use
existing local facilities for healthy lifestyle programs. Par-
ticipants will be stimulated to seek support after DiAlert
from their GP, a dietician or physiotherapist to assist
them with their goals to lose weight.
Pre-testing the intervention
Once the initial draft of the DiAlert intervention was
completed, the intervention was pre-tested by a multidis-
ciplinary panel of diabetes professionals, consisting of a
registered dietician, a diabetes nurse specialist, two
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specialist diabetes psychologists, a research assistant, and
an expert in the field of diabetes risk communication.
The intervention was delivered by a trained psychologist
and a health scientist (WH), both certified PRISMA trai-
ners. The feedback from the professionals’ panel was
overall positive with minor suggestions for further
improvement.
Following a framework for development and evaluation
of RCTs for complex interventions to improve health
(MRC framework) [27] a feasibility and piloting stage was
be performed before embarking on a randomised con-
trolled trial. Twenty first degree relatives of T2DM
patients were invited to participate in a pilot study to
evaluate feasibility, acceptability, participant appreciation,
and questionnaire assessments. Based on the evaluation
of the pilot the intervention modules were adapted before
we set off the RCT.
Cultural adaptation
After implementation of DiAlert in the ethnic Dutch
population, we will assess effectiveness and feasibility of
DiAlert in a population of Turkish people who live in
the region of Amsterdam in the Netherlands. Cultural
adaptation and translations will be performed in order
to target DiAlert for this group. By means of a needs
assessment general information about the community,
demographic data, health status, knowledge of health
and cultural related information will be obtained [28].
Possible ‘mismatches’ in the ethnic Dutch intervention
will be identified through literature review, interviews
Table 1 Outline of the DiAlert programme for first degree relatives of people with type 2 diabetes
Modules Duration
(min)
Sample activity Aim
Session 1 150 min.
- Introduction 10 General introduction trainer and observers are introduced. State aims and proceedings of the two
group sessions.
- Participant topics 30 All participants are asked about family members with T2DM, and will
be encouraged to explore their knowledge, concern and possible
impact of T2DM. Motives for participating and burning questions of
participants are listed.
Introduction of participants, personal
models about T2DM are explored.
- View on personal
risk factors
30 Participants share current knowledge of risk factors for T2DM and
discuss modifiable and non-modifiable risk factors.
Increase risk perception
30 break
- How to prevent
T2DM?
30 Participants learn about insulin resistance, loss of beta cell function
and the positive effects of body weight loss and physical activity.
Increase outcome expectancies for
weight loss and physical activity
- Energy balance 10 Advice based on recommendations on nutrition and physical activity.
Balancing calorie intake and energy expenditure per day.
Increase outcome expectancies for
weight loss and healthy diet
- Homework
assignment
10 Self-monitoring diet and physical activity (diary). Monitoring current lifestyle behaviour
Session 2 150 min.
- Reflections 10 Summary of session 1: Participants reflect on issues raised by the
program so far.
Discussing topics of the first session
- Taking control:
Nutrition and exercise
balance
40 Introduction to calories by comparing different food products. Reading
nutrition fact labels.
Knowledge and skills for food choices
(calorie and fat intake) to reduce risk
factors
30 break
- Personal action plan 45 Sharing experiences about losing weight. Exploring benefits and
barriers for lifestyle change. Participants’ stories are used to summarise
possibilities/facilities to lose weight. Participants formulate personal
action plans to change lifestyle.
Action planning, coping planning and
self efficacy for formulated goals
- Burning questions 15 Check whether all questions raised by participants throughout the two
group sessions have been answered and understood.
All questions of participants are
answered
- Conclusions 10 Summary Conclusions of the two session are
summarised
Newsletters
- 4 Newsletter 4 newsletters are sent by mail with information about health behaviour change
following HAPA framework and tips for healthy eating and increasing physical
activity.
Focus of the 4 newsletters:
1. outcome expectancies and self
efficacy
2. Self efficacy, coping with barriers.
3. Intentions and maintenance
4. Maintenance
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and focus group discussions with lay people from Turk-
ish descent.
Study materials including participant information,
newsletters and leaflets will be translated into Turkish
with regard to core values, beliefs, norms and other sig-
nificant aspects of the groups and lifestyles [29].
Questionnaires will be forward-translated by a bilin-
gual health professional with knowledge of both the
Dutch and Turkish culture, following guidelines of the
WHO for translating instruments [30]. Conceptual
rather than literal translations will be taken into account
by natural and acceptable language. Backward-transla-
tions will be performed by an independent translator
whose mother tongue is Turkish. Comparisons between
the two translations will be performed and discrepancies
will be discussed with both translators.
A pilot test of the culturally targeted intervention will
be carried out in a sample of the target population to
pre-test study materials and modules of DiAlert. Fidelity
and appreciation will be evaluated with questionnaires
and interviews.
Outcome measures
The main outcome measure is change in body weight.
Secondary outcome measures include biological, beha-
vioural and psychological outcomes and perceived health
status. Predictors for weight loss and health behaviour
change (e.g. participant characteristics: gender, initial BMI,
SES, number of family members with diabetes, perceived
risk and perceived seriousness of diabetes) will be assessed.
Measurements
Baseline measurements are planned after randomisation
and follow-up measurements are planned at 3 and 9
months (see Figure 1 for a detailed flowchart). Baseline
and follow-up measurements include physical measures,
laboratory tests and questionnaires.
Physical measures
The anthropometric assessment will be performed in the
GP practice or outpatient clinic by a trained research assis-
tant. Calibrated scales will be used to measure body weight
to the nearest 0.5 kg, wearing light indoor clothing and no
shoes. Height in cm will be measured to the nearest
0.1 cm on bare feet. Waist circumference will be measured
twice with a tape to the nearest 0.1 cm at the level midway
between the lowest rib margin and the iliac crest.
Systolic and diastolic blood pressure (in mmHg) will
be measured in a seated position with a fully automated
blood pressure monitor (OMRON M5-I). All measure-
ments will be performed twice, mean values of the two
measurements will be computed.
Laboratory tests
Fasting blood samples will be drawn at the laboratory to
determine HbA1c, total cholesterol, LDL and HDL-
cholesterol, triglycerides, glucose and insulin, to calcu-
late HOMA [31].
Questionnaires
All participants will be asked to fill out a questionnaire
(20 minutes), either at home via the internet or on
paper. The questionnaire consists of cross-cultural vali-
dated questionnaires when possible.
Participant characteristics
At baseline, socio-demographic data (marital status, high-
est level of completed education, current employment),
reasons to participate in the study, complete family
history of diabetes in first and second degree relatives,
illness and co-morbidity in the past, and use of medica-
tion will be assessed. Ethnicity will be assessed by asking
own and parents’ country of birth, duration of living in
the Netherlands and self-reported ethnicity.
Body weight
Questions about body weight include: a) weight loss his-
tory (number of attempts to lose weight, received weight
counselling by a GP, dietician or physiotherapist during
the past 3 months, desired body weight and body weight
history over the past five years), b) body weight perception
(description of own body weight: answer categories
include ‘thin’, ‘average’, ‘somewhat overweight’ and ‘over-
weight’) and c) Importance of body weight, assessed by a
5-point likert scale from very important to totally not
important.
Lifestyle behaviours
Frequency and amount of fruit, vegetable and snack
intake per week and nutrition habits will be assessed with
a modified version of a frequently used food frequency
questionnaire [32]. Moderate, vigorous physical activity
and the amount of walking per week will be assessed
with the IPAQ short form [33]. Smoking behaviour will
be assessed by asking participants if they are a current
smoker, an ex-smoker, or a never smoker. In case of a
current smoker the number of cigarettes or other tobacco
products will be assessed. Alcohol intake on weekdays
and weekend days will be assessed separately.
Health status
Health outcome will be measured using the EQ5D ques-
tionnaire [34]. The Kessler-10 (K10) [35] will be used to
assess level of psychological distress (e.g. anxiety and
depressive symptoms). The Dutch version of the K10 is
appropriate for screening depressive disorders in primary
care [36]. In addition, life-events occurred in the past 6
months, and psychological treatment in the past will be
assessed.
Determinants of health behaviour change
In the HAPA framework determinants of initial change
have been identified: perceived risk, self-efficacy, outcome
expectancies, leading to intentions and action planning.
Questions about risk perception will include perceived
causal beliefs, consequences and control of diabetes, which
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were derived from the revised Illness Perception Question-
naire (IPQ-R) [37]. In addition, comparative risk (a lot
lower to a lot higher), estimation of risk (very low to very
high) and emotional representation (totally not worried to
very worried) will be assessed with 7-point likert scales
(questions derived from Claassen et al. [38]). Finally, parti-
cipants will be asked to score whether they think that low-
ering the chance of diabetes is: ‘very important to totally
not important’ and ‘very easy to very difficult’.
Self-efficacy for healthy eating and physical activity is
assessed by ten questions using a 4-point likert scale
(very uncertain to very certain) [39].
Outcome expectancies for a healthy diet and increasing
physical activity will be measured with 8 questions with a
5-point likert scale (totally disagree to totally agree) [40]
Intention and action planning to change health beha-
viours will be assessed on a 5-point likert scale ranging
from totally disagree to totally agree, asking participants
whether they plan to consciously eat healthier/exercise
more/lose weight and if they have formulated a detailed
action plan (what, when, how) for changing diet and physi-
cal activity [40].
Process evaluation
To monitor program implementation a process evaluation
will be carried out following a structured process evalua-
tion plan [41]. Fidelity, reach, dose delivered and received
of the intervention and materials will be assessed by
means of a short questionnaire at the end of the second
session. In addition, the health facilitators will be asked to
evaluate the group sessions, directly after each session.
Statistical analysis
Descriptive statistics will be applied to describe the study
population at baseline. To determine the effect of the
intervention on weight loss and to follow individual
change over time we will use generalized linear mixed
models and take into account different settings (e.g. inter-
vention groups, trainers), clustering of family members
and correlation between observations from same subject;
i.e. using a three level structure. Potential confounders and
effect modifiers (e.g. BMI at baseline, SES, gender and age)
will be investigated. To test predictors of weight loss mul-
tiple regression analysis techniques will be performed. The
level of significance is set at p < 0.05.
Ethical approval
The study protocol, information letters and informed
consent form were approved by the Medical Ethics
Review Committee of the VU University Medical Center.
Discussion
This randomised controlled trial is designed to evaluate
the effectiveness of DiAlert in assisting overweight
individuals with a family history of T2DM to lose weight
in order to reduce their risk of developing T2DM. There
is growing evidence for prevention of T2DM by lifestyle.
However, an approach with a focus on family history com-
bined with structured lifestyle education has not been uti-
lized before. We assume that the DiAlert intervention will
prove to be more effective than the control condition in
achieving significant body weight loss at 3 months and
9 months. In addition, we expect to observe significant
changes in metabolic, psychological and behavioural para-
meters following the intervention in both ethnic groups,
resulting in reduced risk of developing T2DM.
The study has some limitations that should be men-
tioned. First, blinding of the participants will be impossible
because they receive the intervention. To limit this bias,
participants will not be informed about the outcomes of
measurements, except when outcomes suggest diagnosis
of diabetes based on guidelines. Furthermore, family
history and overweight is not consistently recorded in
patient registers of the GP in the Netherlands [42], which
might hinder recruitment of participants. Therefore we
will utilise different recruitment strategies. By recording
the recruitment path of each participant, we will be able to
take into account bias due to different motivations of par-
ticipation in the study.
Despite the growing knowledge in the field of primary
prevention, there is an urgent need for well-designed trans-
lational studies in populations at high-risk for diabetes. The
challenge in offering an intervention in a primary care set-
ting is to find the right balance between efficacy (intensity,
follow-ups) and feasibility. Particularly, in the case of peo-
ple who are just at risk for T2DM and not yet medically ill
and not meeting with disadvantages and complications of
the disease. To increase feasibility, the intervention will be
delivered in close proximity to participants’ homes, which
could reduce barriers for participation. In addition, because
DiAlert consists only of two interactive group sessions, we
assume low drop-out rates. At last, delivery in GP practices
or in the outpatient clinic could contribute to the percep-
tion of the reliability of the given information.
A group-based lifestyle education is a practical
method for evidence-based prevention of T2DM in real-
life settings [43]. However, the group composition is
important to consider, particularly with respect to mix
of socio-demographics, health profile (previous health
warnings, overweight) and cultural background. By tar-
geting at a population of Turkish origin we will be able
to reach a broader population at risk for diabetes in the
Netherlands. However, we should take cultural compe-
tence of materials and facilitators into account.
Future implementation
This short, but comprehensive intervention could con-
tribute to the knowledge of prevention of T2DM in
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public health. If DiAlert proves to be effective in reduc-
tion of body weight, implementation will be considered.
The process evaluation will provide us with barriers and
facilitators that can be used to determine the optimal
implementation strategy.
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